ACTIVA 37601

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,l report with the FDA on 2019-05-24 for ACTIVA 37601 manufactured by Medtronic Neuromodulation.

Event Text Entries

[146103650] Age or date of birth: this value is the average age of the patients reported in the article as specific patients could not be identified. Sex: this value reflects the gender of the majority of the patients reported in the article as specific patients could not be identified. Date of event: please note that this date is based off of the date that the article was accepted for publication as the event dates were not provided in the published literature. Description of problem or event: it was not possible to ascertain specific device information from the article or to match the events reported with previously reported events. Correspondence has been sent to the author of the article inquiring about individual patient information and additional information regarding the reported events. Tyagi h, apergis-schoute am, akram h, et al. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: clinical and imaging evidence for dissociable effects. Biol psychiatry. 2019. 10. 1 016/j. Biopsych. 2019. 01. 017. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[146103651] Tyagi h, apergis-schoute am, akram h, et al. "a randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: clinical and imaging evidence for dissociable effects. " biol psychiatry. 2019. 10. 1 016/j. Biopsych. 2019. 01. 017. Six patients with treatment-refractory ocd entered double-blind counterbalanced phases of 12-week anteromedial subthalamic nucleus ( amstn) or ventral capsule/ventral striatal (vc/vs) dbs, followed by 12-week open phases when amstn and vc/vs were stimulated together, in which optimal stimulation parameters were achieved and adjunctive inpatient cognitive behavioral therapy was delivered. Ocd and mood were assessed with standardized scales and cognitive flexibility with the cambridge neuropsychological test automated battery intra-extra dimensional set-shift task. Diffusion-weighted and intraoperative magnetic resonance imaging scans were performed for tractography from optimally activated electrode contacts. It was determined that both the vc/vs and amstn are effective targets for severe treatment-refractory ocd. Reported events: one patient experienced hypomania with alcohol excess and a minor hand fracture. One patient experienced urinary retention in the postoperative phase.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007566237-2019-01165
MDR Report Key8641629
Report SourceFOREIGN,HEALTH PROFESSIONAL,L
Date Received2019-05-24
Date of Report2019-05-24
Date of Event2019-01-03
Date Mfgr Received2019-04-25
Date Added to Maude2019-05-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLISA WOODWARD CLARK
Manufacturer Street7000 CENTRAL AVENUE NE RCW215
Manufacturer CityMINNEAPOLIS MN 55432
Manufacturer CountryUS
Manufacturer Postal55432
Manufacturer Phone7635263920
Manufacturer G1MEDTRONIC NEUROMODULATION
Manufacturer Street800 53RD AVE NE
Manufacturer CityMINNEAPOLIS MN 554211200
Manufacturer CountryUS
Manufacturer Postal Code554211200
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameACTIVA
Generic NameSTIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Product CodeMFR
Date Received2019-05-24
Model Number37601
Catalog Number37601
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC NEUROMODULATION
Manufacturer Address800 53RD AVE NE MINNEAPOLIS MN 554211200 US 554211200


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-05-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.